| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/31/2009 | CA2389749C Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009037556A1 New agents for the treatment of the low urinary tract dysfunctions |
| 03/26/2009 | WO2009036852A1 Medicament for treating or preventing proteinuria |
| 03/26/2009 | WO2008118148A3 Adiponectin for the treatment and diagnosis of albuminuria |
| 03/26/2009 | US20090082446 Use of Hydroxyoleic acid and related compounds in the manufacture of drugs |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082301 Gene therapy for renal failure |
| 03/26/2009 | US20090082291 Methods of treatment of acute renal failure |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081283 Tumor therapy with non-viral-based high affinitiy laminin receptor-targeted vectors |
| 03/26/2009 | US20090081131 Tumor therapy with high affinity laminin receptor-targeted vectors and compounds |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/25/2009 | EP2039695A1 Bicyclic heterocyclic compound and use thereof |
| 03/25/2009 | EP2039363A1 Agent for prevention and/or treatment of glomerulopathy |
| 03/25/2009 | EP2037927A1 Flibanserin for the treatment of urinary incontinence and related diseases |
| 03/25/2009 | EP2037920A1 Use of a cannabinoid cb1 receptor antagonist for preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101395137A Substituted 2-amino-4-phenyl-dhydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them |
| 03/25/2009 | CN101391062A Traditional Chinese medicine preparation for treating nephritis |
| 03/25/2009 | CN101391038A Traditional Chinese medicine formulation for treating transitional cell carcinomal of bladder |
| 03/25/2009 | CN101391009A Medicine composition for treating diabetic nephropathy of deficiency of both qi and yin and accumulation of blood stasis and preparation method thereof |
| 03/25/2009 | CN101391007A Preparation method of soft-capsule of saw palmetto fruit extract |
| 03/25/2009 | CN101390972A Medicine for treating nephritis |
| 03/25/2009 | CN101390918A New uses of Boraginaceae cynoglossum plant and extract thereof in medicine domain |
| 03/25/2009 | CN101390880A Use of sea collagen peptides in preparing medicine or food for protecting kidney function, delaying chronic renal failure |
| 03/25/2009 | CN100471869C Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of coriolus versicolor |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471492C Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507717 Inhibitors of neuronal amine transporters of neurotransmitters, such as noradrenaline, serotonin, dopamine, glutamic acid and glycine; pain, inflammation, incontinence, cardiovascular conditions and mood disorders |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/19/2009 | WO2009035157A1 Therapeutic and/or prophylactic agent for lower urinary tract symptoms after radiotherapy |
| 03/19/2009 | WO2009035055A1 Insulin-like growth factor-1 (igf-1) production promoter |
| 03/19/2009 | WO2009007348A3 Use of antagonists of g protein coupled receptors (gpcrs) for treating diseases caused by agonistic autoantibodies activated gpcrs |
| 03/19/2009 | WO2008037258A8 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 03/19/2009 | US20090076123 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 03/19/2009 | US20090076043 Deuterium-enriched alfuzosin |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075937 Lhrh antagonists for the treatment of lower urinary tract symptoms |
| 03/19/2009 | US20090075923 Methods of treatment of renal disease |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/19/2009 | US20090074722 Products and methods for treating PTP lar diseases |
| 03/19/2009 | DE102007045038A1 Arzneimittel zur Behandlung oder Prävention von Proteinurie Drugs for the treatment or prevention of proteinuria |
| 03/19/2009 | DE102007044032A1 New substituted heteroaryl compounds are hypoxia-inducible factor prolyl-4-hydroxylase inhibitors useful to treat and/or prevent e.g. circulatory heart diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036896A1 Cyclic amine compound |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2035369A1 Therapeutic compounds |
| 03/18/2009 | EP2035021A2 Treatment of mouth and urinary tract infections |
| 03/18/2009 | EP2035009A1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 03/18/2009 | EP2035007A1 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy |
| 03/18/2009 | EP2035004A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 03/18/2009 | EP2034992A2 Method of improved diuresis in individuals with impaired renal function |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | CN201208453Y Traditional Chinese medicine health belt for treating infantile enuresis |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101385841A Traditional Chinese medicine for treating urgent, chronic nephropyeltis |
| 03/18/2009 | CN101385834A Medicine composition for treating urinary system disease and quality control method thereof |
| 03/18/2009 | CN101385786A Traditional Chinese medicine for treating glomerulus disease |
| 03/18/2009 | CN101385768A Chinese azalea root extract, preparation method and use thereof in preparing medicine for treating chronic glomerulus nephritis |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469377C Soft capsule for treating prostatitis |
| 03/18/2009 | CN100469371C Manufacturing technique for gingko leaf extracts |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504415 Therapeutic agent for glomerular disease |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/12/2009 | WO2009032885A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 03/12/2009 | WO2009032538A1 Method of preventing nephrocalcinosis |
| 03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031708A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031635A1 Recombinant vector for treatment of nephrogenic diabetes insipidus, and use thereof |
| 03/12/2009 | WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 03/12/2009 | US20090069421 Crystal polymorph of hydroxynorephedrin derivative hydrochloride |
| 03/12/2009 | US20090069347 2-phenoxy pyrimidinone analogues |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |